Could CannTrust Holdings (TSX:TRST) Stock Recover in 2020?

Here’s why bargain hunters should be placing contrarian bets on beaten-down cannabis stock CannTrust Holdings (TSX:TRST)(NYSE:CTST) today.

question marks written reminders tickets

Image source: Getty Images

A beleaguered CannTrust Holdings’s (TSX:TRST)(NYSE:CTST) stock remains heavily beaten down today, even as the company appears much closer to regaining its licences and has preserved cash flow during the period with suspended operating licences.

Shares traded around $1.20 exit 2019, and they had recorded an agonizing low of $0.99 a share recently — a price point too bearish, even after considering the self-inflicted crisis the company finds itself in today.

Let me explain.

Trading below cash value?

At a share price of $1.20 on Thursday, the company’s total market capitalization was a humble $169 million. Yet management disclosed that CannTrust had a cash balance of around $185 million on in its coffers as of November 30, 2019.

Barely a month later, investors had discounted this liquid resource by a significant margin, and written off all the company’s tangible assets. There isn’t any goodwill on TRST’s books. All tangible assets, including grow rooms and processing facilities, were essentially written off by the market.

You could theoretically buy the whole company for its cash resources and make a staggering profit just by winding up its operations and selling off property and plant and equipment assets at giveaway prices in a fire sale auction.

The company promised to temporarily lay off about 140 of its employees between October and December 31 to save about $0.4 million in cash flow per month, and the move will only cost about $0.8 million in severance packages if the individuals aren’t re-hired within 35 weeks. The cash balance could stretch for longer.

No debt in capital structure

There’s no debt on the company’s books after the last loan was paid off before maturity, so there aren’t any debts to worry about anymore.

And then the licences…

The company could potentially be back in compliance with Health Canada’s guidelines and regulatory requirements within three months from now.

Reading from a December 5, 2019, update, management could meet the conditions for the reinstatement of their suspended business licences by the end of the first quarter of 2020, but this will be subject to Health Canada input and approval.

As I argued earlier, the regulator has been very lenient with this once-rogue pot producer, and it was up to a serious executive team to bring the company back in good terms with the key stakeholder with an average effort.

News of licences reinstatement could violently lift the stock from today’s trading levels.

Potential risks

Several investor class-action lawsuits have been served or still in the process of being filed. There should be some strong evidence against the company if media reports that claimed that even the CEO was an accomplice in the scandal are to be taken seriously.

Lawsuits could drain all liquidity and sink the firm forever, but there could be some insurance cover against such operational risk eventualities, and some property could still be sold to cover these.

Further, the company is yet to file its restated financial statements for the year 2018 and subsequent quarterly instalments. The longer it takes for these required documents to be lodged with securities regulators, the higher the risk of shares being delisted from exchanges. Delisted stocks face very high discounts for lack of liquidity.

The further shares trade below US$1.00 on the New York Stock Exchange, the higher the risk of delisting from this prime market, but the company has over five months to be back in compliance with minimum price requirements there, and the share price may skyrocket upon news of licences reinstatement much sooner.

Keen eyes are on the suspended licences. Sales need to resume for the accumulated inventory to be liquidated and bring in cash flow to the business. The longer it takes for licences to be granted, the harder it will be to revive the business and directly compete with peers for customers in an increasingly oversupplied marijuana market.

Foolish bottom line

It will be a challenge for CannTrust to regain market confidence and trust from all key stakeholders after the scandal settles. Risks remain elevated and keep increasing with each additional week that sales licences remain suspended.

I would still hold a position and anticipate to cash in when the good news rolls in.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings and CannTrust Holdings Inc.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »